MAUDE MDR 934939

MDR report key
934939
Report number
2013342-2007-00008
Event key
0
Event type
3
Date of event
2007-08-15
Date received
2007-10-30
Adverse event
3
Product problem
3
Patients in event
0
Reporter occupation
0
Health professional
3
Initial report to FDA
3
Event location
3

Manufacturer Contact#

Contact
DR. LEONARD BERMAN
Address
25 HARBOR PARK DR PORT WASHINGTON NY 11050 US
Phone
516-516-5168
Report source
M
Manufacturer link flag
Y

Devices#

Seq, Brand, Generic table
SeqBrandGenericManufacturerProduct codeModelCatalogLotPMA510(k)ImplantEvaluatedAvailability
1PALL BDS SAMPLE SETMZC: IMMUNOLOGY (SPECIALITY)PALL MEDSEPMZCBDS02NA0754039NYN

Patients#

Sequence, Received, Treatment table
SequenceReceivedTreatmentOutcome
12007-10-300

Event Narratives#

D

Patient 1

IT WAS REPORTED THAT A UNIT OF PLATELETS WAS SAMPLED AND TESTED FIVE DAYS AFTER THE APHERESIS UNIT HAD BEEN COLLECTED IN A HOSPITAL BLOOD BANK PRIOR TO ISSUE, AND WAS FOUND TO HAVE A PH OF 5.7. THE UNIT WAS THEN SUBMITTED TO THE HOSPITAL LABORATORY FOR CONFIRMATORY CULTURE TESTING, IN WHICH GROWTH WAS OBSERVED, IDENTIFIED AS GRAM-POSITIVE COCCL (GPC). THE PLATELET UNIT WAS DISCARDED (NOT TRANSFUSED TO A PATIENT). THE PLATELET UNIT HAD PREVIOUSLY BEEN TESTED WITH THE BACTERIAL DETECTION DEVICE, WHICH HAD MADE A DETERMINATION, BASED ON A HEADSPACE OXYGEN CONCENTRATION OF 14.98%, THAT THE UNIT WAS NOT CONTAMINATED.

N

Patient 1

DEVICE EVALUATION STARTED, BUT NOT YET COMPLETED.

N

Patient 1

A REVIEW OF THE RELEASE TESTING OF THE OXYGEN ANALYZER CONFIRMED THAT THE INSTRUMENT CONFORMED TO SPECIFICATIONS REQUIRED FOR RELEASE. A REVIEW OF THE MANUFACTURING HISTORY FOR THE SAMPLE POUCH LOT USED IN THE TESTING INDICATED NO DEVIATION THAT WOULD BE LIKELY TO BE RELATED TO THE USER'S REPORTS. NO SIMILAR REPORTS HAVE BEEN REPORTED FROM OTHER BLOOD CENTERS USING THIS LOT. BECAUSE THE SAMPLE POUCH INVOLVED IN THE EVENT WAS DISCARDED, AND SPECIMENS OF THE GROWN-OUT BACTERIA WERE NOT PROVIDED TO THE FIRM FOR AN ATTEMPTED REPRODUCTION OF THE REPORTED EVENT, THE CONCLUSIONS STATED BELOW ARE BASED ON INFORMATION, INCLUDING THE DATA LOG RETRIEVED FROM THE OXYGEN ANALYZER, PROVIDED TO THE FIRM BY THE USER. IT IS LIKELY THAT THE APHERESIS UNIT IN QUESTION WAS CONTAMINATED. THIS IS SUPPORTED BY LOW PH READINGS AND THE HOSPITAL LABORATORY'S CONFIRMATORY CULTURE TEST RESULTS. THERE IS NO INDICATION DURING REVIEW OF THE DATA LOG THAT THERE WAS A MALFUNCTION OF THE OXYGEN ANALYZER. THE MEASURED OXYGEN LEVEL OF 14.98% THAT WAS RECORDED IN THE DATA LOG, WHICH CORRESPONDS TO A "PASS" RESULT IS TYPICAL OF NON-CONTAMINATED SAMPLES FROM AN APHERESIS UNIT. BASED ON THIS INFORMATION, THE MOST PROBABLE CAUSE OF THE PASS DETERMINATION FROM THE EBDS BACTERIAL DETECTION SYSTEM IS THAT THE LEVEL OF BACTERIA (CFU/ML) IN THE APHERESIS UNIT WAS SUFFICIENTLY LOW THAT THE 4 ML SAMPLE FROM THE PLATELET UNIT DID NOT INCLUDE VIABLE BACTERIA. THIS PHENOMENON IS A RESULT OF THE STATISTICAL VARIATION IN SAMPLING. THIS PHENOMENON IS DESCRIBED IN THE LABELING FOR THE EBDS: THE HOSPITAL BLOOD BANK'S POLICY IS TO SCREEN PLATELETS PRIOR TO ISSUANCE FROM TRANSFUSION. IN THIS CASE, THE SCREEN EXCLUDED THIS PLATELET UNIT, AND THE PLATELETS WERE NOT ISSUED FOR TRANSFUSION. THERE WERE NO CLINICAL SEQUELAE.UNLESS SUBSTANTIALLY SIGNIFICANT INFORMATION BECOMES AVAILABLE, THIS CONSTITUTES A FINAL REPORT.